Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2007 Sep 2:141–178. doi: 10.1016/B978-012369454-6/50034-0

Mouse Hepatitis Virus

Stephen W Barthold 1,2,3,4,5,6, Abigail L Smith 1,2,3,4,5,6
Editors: James G Fox1,2,3,4,5,6, Muriel T Davisson1,2,3,4,5,6, Fred W Quimby1,2,3,4,5,6, Stephen W Barthold1,2,3,4,5,6, Christian E Newcomer1,2,3,4,5,6, Abigail L Smith1,2,3,4,5,6
PMCID: PMC7155451

Publisher Summary

This chapter attempts to provide an overview of the important aspects of mouse hepatitis virus (MHV) experimental biology while emphasizing the virus as a naturally occurring mouse pathogen. Even this is complicated, as it is impossible to generalize with this virus, due to marked differences in the biologic behavior of the myriad virus strains, plus the marked effects of a large number of host factors. It is now known that the MHV group is represented by numerous variants that are constantly mutating, and that these viruses can be biologically separated into respiratory (polytropic) MHVs and enterotropic MHVs, with distinctly different patterns of tissue tropism. This dichotomy is emphasized for discussion, but biology is never absolute. Many of the early MHV isolations are made as a result of contamination of biological materials that correlated with their polytropic biologic behavior. Their stated tropisms frequently were the result of the investigators' research interests and many have therefore been subjected to selective passage that favors a particular tissue tropism. All MHV isolates are related genetically and antigenically, but isolates can be differentiated by genetic sequencing, cross-serum neutralization, or with monoclonal antibodies. Genetic and antigenic relationships are not predictive of biologic behavior.

References

  1. Adami C., Pooley J., Glomb J. Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology. 1995;209:337–346. doi: 10.1006/viro.1995.1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asanaka M., Lai M.M. Cell fusion studies identified multiple cellular factors involved in mouse hepatitis virus entry. Virology. 1993;197:732–741. doi: 10.1006/viro.1993.1649. [DOI] [PubMed] [Google Scholar]
  3. Bailey O.T., Pappenheimer A.M., Cheever F.S., Daniels J.B. A murine virus (JHM) causing disseminated encephalomyelitis with exten-sive destruction of myelin. II. Pathology. J Exp Med. 1949;90:195–212. doi: 10.1084/jem.90.3.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bang F.B. Genetics of resistance of animals to viruses. I. Introduction and studies in mice. Adv Virus Res. 1978;23:269–348. doi: 10.1016/S0065-3527(08)60102-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bang F.B., Warwick A. Mouse macrophages as host cells for the mouse hepatitis virus and the genetic basis of their susceptibility. Proc Natl Acad Sci USA. 1960;46:1065–1075. doi: 10.1073/pnas.46.8.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Banner L.R., Keck J.G., Lai M.M. A clustering of RNA recom-bination sites adjacent to a hypervariable region of the peplomer gene of murine coronavirus. Virology. 1990;175:548–555. doi: 10.1016/0042-6822(90)90439-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Baric R.S., Fu K., Schaad M.C., Stohlman S.A. Establishing a genetic recombination map for murine coronavirus strain A59 complemen-tation groups. Virology. 1990;177:646–656. doi: 10.1016/0042-6822(90)90530-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Baric R.S., Sullivan E., Hensley L., Yount B., Chen W. Persistent infection promotes cross-species transmissibility of mouse hepati-tis virus. J Virol. 1999;73:638–649. doi: 10.1128/jvi.73.1.638-649.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Baric R.S., Yount B., Hensley L., Peel S.A., Chen W. Episodic evolution mediates interspecies transfer of a murine coronavirus. J Virol. 1997;71:1946–1955. doi: 10.1128/jvi.71.3.1946-1955.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Barnett E., Cassell M., Perlman S. Two neurotropic viruses herpes simplex virus type 1 and mouse hepatitis virus spread along differ-ent neural pathways from the main olfactory bulb. Neuroscience. 1993;157:1007–1025. doi: 10.1016/0306-4522(93)90045-H. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Barnett E.M., Perlman S. The olfactory nerve and not the trigem-inal nerve is the major site of CNS entry for mouse hepatitis virus strain JHM. Virology. 1993;194:185–191. doi: 10.1006/viro.1993.1248. [DOI] [PubMed] [Google Scholar]
  12. Barthold S.W. Mouse hepatitis virus biology and epizootiology. In: Bhatt P.N., Jacoby R.O., Morse H.C. III, New A.E., editors. Viral and mycoplasmal infections of laboratory rodents: effects on bioméd-ical research. Academic Press; Orlando FL: 1986. pp. 571–601. [Google Scholar]
  13. Barthold S.W. Mouse hepatitis virus brain mouse. In: Jones T.C., Mohr U., Hunt R.D., editors. Monographs on pathology of laboratory animals: nervous system. Springer-Verlag; New York: 1988. pp. 180–186. [Google Scholar]
  14. Barthold S.W. Olfactory neural pathway in mouse hepatitis virus nasoen-cephalitis. Acta Neuropathol (Berl) 1988;76:502–506. doi: 10.1007/BF00686390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Barthold S.W. Mouse hepatitis virus infection intestine mouse. In: Jones T.C., Popp J.A., Mohr U., editors. Monographs on pathology of laboratory animals: digestive system. Springer-Verlag; New York: 1997. pp. 379–384. [Google Scholar]
  16. Barthold S.W. Mouse hepatitis virus infection liver mouse. In: Jones T.C., Popp J.A., Mohr U., editors. Monographs on pathology of laboratory animals: digestive system. Springer-Verlag; New York: 1997. pp. 179–184. [Google Scholar]
  17. Barthold S.W., Beck D.S., Smith A.L. Enterotropic coronavirus (mouse hepatitis virus) in mice: influence of host age and strain on infection and disease. Lab Anim Sci. 1993;43:276–284. [PubMed] [Google Scholar]
  18. Barthold S.W., Beck D.S., Smith A.L. Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype. Archiv Virol. 1986;91:247–256. doi: 10.1007/BF01314284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Barthold S.W., Beck D.S., Smith A.L. Mouse hepatitis virus and host determinants of vertical transmission and maternally-derived passive immunity in mice. Arch Virol. 1988;100:171–183. doi: 10.1007/BF01487681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Barthold S.W., deSouza M.S., Smith A.L. Susceptibility of labo-ratory mice to intranasal and contact infection with coronaviruses of other species. Lab Anim Sci. 1990;40:481–485. [PubMed] [Google Scholar]
  21. Barthold S.W., Sidman C.L., Smith A.L. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunode-ficiency. Am J Trop Med Hyg. 1992;47:605–613. doi: 10.4269/ajtmh.1992.47.605. [DOI] [PubMed] [Google Scholar]
  22. Barthold S.W., Smith A.L. Duration of challenge immunity to coronavirus JHM in mice. Arch Virol. 1989;107:171–177. doi: 10.1007/BF01317914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Barthold S.W., Smith A.L. Duration of mouse hepatitis virus infection: studies in immunocompetent and chemically immunosuppressed mice. Lab Anim Sci. 1990;40:133–137. [PubMed] [Google Scholar]
  24. Barthold S.W., Smith A.L. Mouse hepatitis virus S in weanling Swiss mice following intranasal inoculation. Lab Anim Sci. 1983;33:355–360. [PubMed] [Google Scholar]
  25. Barthold S.W., Smith A.L. Mouse hepatitis virus strain-related patterns of tissue tropism in suckling mice. Archiv Virol. 1984;81:103–112. doi: 10.1007/BF01309300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Barthold S.W., Smith A.L. Response of genetically susceptible and resistant mice to intranasal inoculation with mouse hepatitis virus JHM. Virus Res. 1987;7:225–239. doi: 10.1016/0168-1702(87)90030-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Barthold S.W., Smith A.L. Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice. Arch Virol. 1992;122:35–444. doi: 10.1007/BF01321116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Barthold S.W., Smith A.L. Virus strain specificity of challenge immunity to coronavirus. Arch Virol. 1989;104:187–196. doi: 10.1007/BF01315542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Barthold S.W., Smith A.L., Lord P.F.S., Bhatt P.N., Jacoby R.O. Epizootic coronaviral typhlocolitis in suckling mice. Lab Anim Sci. 1982;32:376–383. [PubMed] [Google Scholar]
  30. Barthold S.W., Smith A.L., Povar M.L. Enterotropic mouse hep-atitis virus infection in nude mice. Lab Anim Sci. 1985;35:613–618. [PubMed] [Google Scholar]
  31. Beauchemin N.P., Draber P., Dveksler G. Redefined nomencla-ture for members of the carcinoembryonic antigen family. Exp Cell Res. 1999;252:243–249. doi: 10.1006/excr.1999.4610. [DOI] [PubMed] [Google Scholar]
  32. Belyavsky M., Belyavskaya E., Levy G.A., Leibowitz J.L. Coronavirus MHV-3-induced apoptosis in macrophages. Virology. 1998;250:41–49. doi: 10.1006/viro.1998.9356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Bergmann C.C., Ramakrishna C., Kornacki M., Stohlman S.A. Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection. J Immunol. 2001;167:1575–1583. doi: 10.4049/jimmunol.167.3.1575. [DOI] [PubMed] [Google Scholar]
  34. Besselsen D.G., Wagner A.M., Loganbill J.K. Detection of rodent coronaviruses by use of fluorogenic reverse transcriptase-polymerase chain reaction analysis. Comp Med. 2002;52:111–116. [PubMed] [Google Scholar]
  35. Biggers D.C., Kraft L.M., Sprinz H. Lethal intestinal virus of mice (LIVIM) . An important new model for study of response of the intes-tinal mucosa to injury. Am J Pathol. 1964;45:413–422. [PMC free article] [PubMed] [Google Scholar]
  36. Blau D.M., Turbide C., Tremblay M. Targeted disruption of the Ceacaml (MHVR) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection. J Virol. 2001;75:8173–8186. doi: 10.1128/JVI.75.17.8173-8186.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Bootz F., Sieber I., Popovic D., Tischhauser M., Hornberger F.R. Comparison of the sensitivity of in vitro antibody production tests with in vitro PCR-based methods to detect infectious contamination of biological material. Lab Anim. 2003;37:341–351. doi: 10.1258/002367703103051895. [DOI] [PubMed] [Google Scholar]
  38. Brambell F.W.R., Hemmings W.A. The transmission of antibodies from mother to fetus. In: Villee C.A., editor. The placenta and fetal membranes. Williams and Wilkins; Baltimore: 1960. pp. 71–84. [Google Scholar]
  39. Broderson J.R., Murphy F.A., Hierholzer J.C. Lethal enteritis in infant mice caused by a mouse hepatitis virus. Lab Anim Sci. 1976;26:824. [PubMed] [Google Scholar]
  40. Brownstein D.G., Barthold S.W. Mouse hepatitis virus immuno-fluroescence in formalin-or Bouin's-fixed tissues using trypsin digestion. Lab Anim Sci. 1982;32:37–39. [PubMed] [Google Scholar]
  41. Buchmeier M.J., Lewicki H.A., Talbot P.J., Knobler R.L. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984;132:261–270. doi: 10.1016/0042-6822(84)90033-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Cabirac G.F., Soike K.F, Zhang J.-Y. Entry of coronavirus into primate CNS following peripheral infection. Microb Pathog. 1994;16:349–357. doi: 10.1006/mpat.1994.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Carthew P. Lethal intestinal virus of infant mice is mouse hepatitis virus. Vet Rec. 1977;101:465. [PubMed] [Google Scholar]
  44. Carthew P., Gannon J., Whisson I. Comparison of alkaline phos-phatase and horseradish peroxidase conjugated antisera in the ELISA test for antibodies to reovirus3 mouse hepatitis and Sendai viruses. Lab Anim. 1981;15:69–73. doi: 10.1258/002367781780958504. [DOI] [PubMed] [Google Scholar]
  45. Carthew P., Wood M.J., Kirby C. Pathogenicity of mouse hepati-tis virus for preimplantation embryos. J Reprod Fertil. 1985;73:207–213. doi: 10.1530/jrf.0.0730207. [DOI] [PubMed] [Google Scholar]
  46. Casebolt D.B., Qian B., Stephensen C.B. Detection of enterotropic mouse hepatitis virus fecal excretion by polymerase chain reaction. Lab Anim Sci. 1997;47:6–10. [PubMed] [Google Scholar]
  47. Cheever F.S., Daniels J.B., Pappenheimer A.M. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin: I. Isolation and biologic properties. J Exp Med. 1949;90:181–194. doi: 10.1084/jem.90.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Chen D.S., Asanaka M., Chen ES., Shively J.E., Lai M.M.C. Human carcinoembryonic antigen and biliary glycoprotein can serve as mouse hepatitis virus receptors. J Virol. 1997;71:1688–1691. doi: 10.1128/jvi.71.2.1688-1691.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Chen D.S., Asanaka M., Yokomori K. A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc Natl Acad Sci USA. 1995;92:12095–12099. doi: 10.1073/pnas.92.26.12095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Chen W., Baric R.S. Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host resistance and virus virulence. J Virol. 1996;70:3947–3960. doi: 10.1128/jvi.70.6.3947-3960.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Choi Y.-K., Choi J.-Y., Won H.-S. Spontaneous low-virulence mouse hepatitis virus infection in severe combined immunodeficiency mice. Lab Anim Sci. 1999;49:324–327. [PubMed] [Google Scholar]
  52. Collins A.R., Knobler R.L., Powell H., Buchmeier M.J. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 1982;119:358–371. doi: 10.1016/0042-6822(82)90095-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Compton S.R. Enterotropic strains of MHV coronavirus differ in their use of murine carcinoembryonic antigen-related glycoprotein receptors. Virology. 1994;203:197–201. doi: 10.1006/viro.1994.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Compton S.R. Interaction of enterotropic mouse hepatitis viruses with Bgp2 receptor proteins. Adv Exp Med Biol. 1998;440:25–31. doi: 10.1007/978-1-4615-5331-1_4. [DOI] [PubMed] [Google Scholar]
  55. Compton S.R., Ball-Goodrich L.J., Johnson L.K., Johnson E.A., Paturzo F.X., Macy J.D. Pathogenesis of enterotropic mouse hepatitis virus in immunocompetent and immunodeficient mice. Comp Med. 2004;54:681–689. [PubMed] [Google Scholar]
  56. Compton S.R., Ball-Goodrich L.J., Paturzo F.X., Macy J.D. Transmission of enterotropic mouse hepatitis virus from immunocompetent and immunodeficient mice. Comp Med. 2004;54:29–35. [PubMed] [Google Scholar]
  57. Compton S.R., Ball-Goodrich L.J., Zeiss C.J., Johnson L.K., Johnson E.A., Macy J.D. Pathogenesis of mouse hepatitis virus infection in gamma interferon-deficient mice is modulated by co-infection with Helicobacter hepaticus. Comp Med. 2003;53:197–206. [PubMed] [Google Scholar]
  58. Compton S.R., Hornberger F.R., Paturzo EX., Mac Arthur-Clark J. Efficacy of three microbiological monitoring methods in a ventilated cage rack. Comp Med. 2004;54:382–392. [PubMed] [Google Scholar]
  59. Compton S.R., Stephensen C.B., Snyder S.W., Weismiller D.G., Holmes K.V. Coronavirus species specificity: murine coronavirus binds to a mouse-specific epitope on its carcinoembryonic antigen-related receptor glycoprotein. J Virol. 1992;66:7420–7428. doi: 10.1128/jvi.66.12.7420-7428.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Compton S.R., Winograd D.F., Gaertner D.J. Optimization of in vitro growth conditions for enterotropic murine coronaviruses. J Virol Methods. 1995;52:301–307. doi: 10.1016/0166-0934(94)00161-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Croy B.A., Percy D.H. Diagnostic exercise: viral hepatitis in scid mice. Lab Anim Sci. 1993;43:193–194. [PubMed] [Google Scholar]
  62. Dalziel R.G., Lampert P.W., Talbot P.J., Buchmeier M.J. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J Virol. 1986;59:463–471. doi: 10.1128/jvi.59.2.463-471.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Dandekar A.A., Anghelina D., Perlman S. Bystander CD8 T-cell-mediated demyelination is interferon-gamma-dependent in a coronavirus model of multiple sclerosis. Am J Pathol. 2004;164:363–369. doi: 10.1016/S0002-9440(10)63126-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Dandekar A.A., Perlman S. Virus-induced demyelination in nude mice is mediated by gamma/delta T cells. Am J Pathol. 2002;161:1255–1263. doi: 10.1016/s0002-9440(10)64402-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Dandekar A.A., Wu G.F., Pewe L., Perlman S. Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with neurotropic coronavirus. J Virol. 2001;75:6115–6120. doi: 10.1128/JVI.75.13.6115-6120.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Daniel C., Anderson R., Buchmeier M.J. Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure. J Virol. 1993;67:1185–1194. doi: 10.1128/jvi.67.3.1185-1194.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. DasSarma J., Fu L., Tsai J.C., Weiss S.R., Lavi E. Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J Virol. 2000;74:9206–9213. doi: 10.1128/jvi.74.19.9206-9213.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. David-Ferreira J.F., Manaker R.A. An electron microscope study of the development of a mouse hepatitis virus in tissue culture cells. J Cell Biol. 1965;24:57. doi: 10.1083/jcb.24.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. deSouza M.S., Smith A.L. Characterization of accessory cell function during acute infection of BALB/cByJ mice with mouse hepatitis virus (MHV) strain JHM. Lab Anim Sci. 1991;41:112–118. [PubMed] [Google Scholar]
  70. deSouza M.S., Smith A.L. Comparison of isolation in cell culture with conventional and modified mouse antibody production tests for detection of murine viruses. J Clin Microbiol. 1989;27:185–187. doi: 10.1128/jcm.27.1.185-187.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. deSouza M.S., Smith A.L., Bottomley K. Infection of BALB/cByJ mice with the JHM strain of mouse hepatitis virus alters in vitro splenic T cell proliferation and cytokine production. Lab Anim Sci. 1991;41:99–105. [PubMed] [Google Scholar]
  72. Dick G.W.A., Niven J.S.F., Gledhill A.W. A virus related to that causing hepatitis in mice (MHV) Brit J Exp Path. 1956;37:90–98. [PMC free article] [PubMed] [Google Scholar]
  73. Ding J.W., Ning Q., Liu M.F. Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J Virol. 1997;71:9223–9230. doi: 10.1128/jvi.71.12.9223-9230.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Ding J.W., Ning Q., Liu M.F. Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection. Adv Exp Med Biol. 1998;440:609–618. doi: 10.1007/978-1-4615-5331-1_79. [DOI] [PubMed] [Google Scholar]
  75. Dupuy J.M., Levy-Leblond E., LePrevost C. Immunopathology of mouse hepatitis virus type 3 infection. II. Effect of immunosuppression in resistant mice. J. Immunol. 1975;114:221–225. [Google Scholar]
  76. Dveksler G.S., Diffenbach C.W., Cardellichio C.B. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus A59. J Virol. 1993;67:1–8. doi: 10.1128/jvi.67.1.1-8.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Dveksler G.S., Pensiero M.N., Cardelichio C.B. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J Virol. 1991;65:6881–6891. doi: 10.1128/jvi.65.12.6881-6891.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Fazakerley J.F., Parker S.E., Bloom F., Buchmeier M.J. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology. 1992;187:178–188. doi: 10.1016/0042-6822(92)90306-A. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Fingerote R.J., Abecassis M., Phillips M.J. Loss of resistance to murine hepatitis virus strain 3 infection after treatment with cortico-steroids is associated with induction of macrophage procoagulant activity. J Virol. 1996;70:4275–4282. doi: 10.1128/jvi.70.7.4275-4282.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Flanagan S.P. “Nude” a new hairless gene with pleiotropic effects in the mouse. Genet Res. 1966;8:295–309. doi: 10.1017/s0016672300010168. [DOI] [PubMed] [Google Scholar]
  81. Fleming J.O., Adami C., Pooley J. Mutations associated with viral sequences isolated from mice persistently infected with MHV-JHM. Adv Exp Med Biol. 1995;380:591–595. doi: 10.1007/978-1-4615-1899-0_94. [DOI] [PubMed] [Google Scholar]
  82. Fleming J.O., Shubin R.A., Sussman M.A., Casteel N., Stohlman S.A. Monoclonal antibodies to the matrix (El) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology. 1989;168:162–167. doi: 10.1016/0042-6822(89)90415-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Fleming J.O., Trousdale M.D., el-Zaatari F.A., Shohlman S.A., Weiner L.P. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol. 1986;58:869–875. doi: 10.1128/jvi.58.3.869-875.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. France M.P., Smith A.L., Stevenson R., Barthold S.W. Granulomatous peritonitis and pleuritis in interferon-gamma gene knockout mice naturally infected with mouse hepatitis virus. Aust Vet J. 1999;77:600–604. doi: 10.1111/j.1751-0813.1999.tb13199.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Franks L.M., Hemmings V.J. A cell line from an induced carci-noma of mouse rectum. J Pathol. 1978;124:35–38. doi: 10.1002/path.1711240108. [DOI] [PubMed] [Google Scholar]
  86. Fujiwara K., Ohno E., Kadowaki Y. Modification de la response de la souris (nude) contre le virus de l'hepatite murine par transfert des cellules splenique heterozygotes. Comptes Rend Soc Biol. 1978;172:814–818. [PubMed] [Google Scholar]
  87. Galanti B., Balestrieri G.G., Piccinino F., Izzo E. Study of possible effect of prednisolone on placental impermeability to MHV-3 virus in pregnant mice. Boll Soc Ital Biol Sper. 1969;45:325–327. [PubMed] [Google Scholar]
  88. Gallagher T.M. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J Virol. 1997;71:3129–3137. doi: 10.1128/jvi.71.4.3129-3137.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Gallagher T.M., Buchmeier M.J. Coronavirus spike proteins in viral entry and pathogenesis. Virology. 2001;279:371–374. doi: 10.1006/viro.2000.0757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Gallagher T.M., Buchmeier M.J., Perlman S. Cell receptor-independent infection by a neurotropic murine coronavirus. Virology. 1992;191:517–522. doi: 10.1016/0042-6822(92)90223-C. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Gallagher T.M., Escarmis C., Buchmeier M.J. Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J Virol. 1991;65:1916–1928. doi: 10.1128/jvi.65.4.1916-1928.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Gallagher T.M., Parker S.E., Buchmeier M.J. Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. J Virol. 1990;64:731–741. doi: 10.1128/jvi.64.2.731-741.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Gallily R., Warwick A., Bang KB. Effect of cortisone on genetic resistance to mouse hepatitis virus in vivo and in vitro. Proc Natl Acad Sci USA. 1964;51:1158–1164. doi: 10.1073/pnas.51.6.1158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Glass W.G., Chen B.P., Liu M.T., Lane T.E. Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease. Viral Immunol. 2002;15:261–272. doi: 10.1089/08828240260066215. [DOI] [PubMed] [Google Scholar]
  95. Gledhill A.W. Quantitative aspects of the enhancing action of Eperythrozoa on the pathogenicity of mouse hepatitis virus. J Gen Microbiol. 1956;15:292–304. doi: 10.1099/00221287-15-2-292. [DOI] [PubMed] [Google Scholar]
  96. Gledhill A.W., Andrewes C.H. A hepatitis virus of mice. Br J Exp Pathol. 1951;32:559–568. [PMC free article] [PubMed] [Google Scholar]
  97. Gledhill A.W., Niven J.S.R. Latent virus as exemplified by mouse hepatitis virus (MHV) Vet Rev Annot. 1955;1:82–84. [Google Scholar]
  98. Godfraind C., Holmes K.V., Coutelier J.P. Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice. J Virol. 1995;69:6541–6547. doi: 10.1128/jvi.69.10.6541-6547.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Gombold J.L., Hingley S.T., Weiss S.R. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J Virol. 1993;67:4504–4512. doi: 10.1128/jvi.67.8.4504-4512.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Gonzalez J.M., Gomez-Puertas P., Cavanagh D., Gorbalenya A.E., Enjuanes L. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch Virol. 2003;148:2207–2235. doi: 10.1007/s00705-003-0162-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Goto N., Hirano N., Aiuchi M., Hayashi T., Fujiwara K. Nasoencephalopathy of mice infected intranasally with a mouse hepatitis virus JHM strain. Jpn J Exp Med. 1977;47:59–70. [PubMed] [Google Scholar]
  102. Gustafsson E., Blomqvist G., Bellman A., Homdahl R., Mattsson A., Mattsson R. Maternal antibodies protect immunoglobulin deficient neonatal mice from mouse hepatitis virus (MHV)-associated wasting syn-drome. Am J Reprod Immunol. 1996;36:33–99. doi: 10.1111/j.1600-0897.1996.tb00136.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Haring J.S., Perlman S. Bystander CD4 T cells do not mediate demyelination in mice infected with a neurotropic coronavirus. J Neuroimmunol. 2003;137:42–50. doi: 10.1016/S0165-5728(03)00041-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Hartley J., Rowe W., Bloom H., Turner H. Antibodies to mouse hepatitis virus in human sera. Proc Soc Exp Biol Med. 1963;115:414–418. doi: 10.3181/00379727-115-28928. [DOI] [PubMed] [Google Scholar]
  105. Hasony H.J., Macnaughton M.R. Antigenicity of mouse hepatitis virus subcomponents in C57 strain mice. Arch Virol. 1981;69:33–41. doi: 10.1007/BF01315263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Hayashi M., Ishida K., Maeda A. Intramuscular injection of plasmid DNA expressing mRNA7 coding the nucleocapsid protein of JHMV partially protected mice against acute infection with JHMV. Adv Exp Med Biol. 1998;440:693–699. doi: 10.1007/978-1-4615-5331-1_89. [DOI] [PubMed] [Google Scholar]
  107. Hensley L.E., Baric R.S. Human biliary glycoproteins function as receptors for interspecies transfer of mouse hepatitis virus. Adv Exp Med Biol. 1998;440:43–52. doi: 10.1007/978-1-4615-5331-1_6. [DOI] [PubMed] [Google Scholar]
  108. Hensley L.E., Holmes K.V., Beauchemin N., Baric R.S. Virus-receptor interactions and interspecies transfer of a mouse hepatitis virus. Adv Exp Med Biol. 1998;440:33–41. doi: 10.1007/978-1-4615-5331-1_5. [DOI] [PubMed] [Google Scholar]
  109. Hierholzer J.C., Broderson J.R., Murphy RA. New strain of mouse hepatitis virus as the cause of lethal enteritis in infant mice. Infect Immun. 1979;24:508–522. doi: 10.1128/iai.24.2.508-522.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Hirano N., Murakami T., Fujiwara K., Matsumoto M. Utility of mouse cell line DBT for propogation and assay of mouse hepatitis virus. Jpn J Exp Med. 1978;48:71–75. [PubMed] [Google Scholar]
  111. Hirano N., Takenaka S., Fujiwara K. Pathogenicity of mouse hepatitis virus for mice depending upon host age and route of infection. Jpn J Exp Med. 1975;45:285–292. [PubMed] [Google Scholar]
  112. Hirano N., Tamura T., Taguchi F. Isolation of low virulent mouse hepatitis virus from nude mice with wasting syndrome and hepatitis. Jpn J Exp Med. 1975;45:429–432. [PubMed] [Google Scholar]
  113. Hobbs G.L., Sanford K.K., Evans V.J., Earle W.R. Establishment of mouse liver cells from a single isolated cell. J Natl Cancer Inst. 1957;18:701–707. [PubMed] [Google Scholar]
  114. Holmes K.V., Behnke J.N. Evolution of a coronavirus during persistent infection in vitro. Adv Exp Med Biol. 1981;142:287–299. doi: 10.1007/978-1-4757-0456-3_23. [DOI] [PubMed] [Google Scholar]
  115. Holmes K.V., Welsh R.M., Haspel M.V. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes. J Immunol. 1986;136:1446–1453. [PubMed] [Google Scholar]
  116. Hornberger F.R. Maternally-derived passive immunity to enterotropic mouse hepatitis virus. Arch Virol. 1992;122:133–141. doi: 10.1007/BF01321123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Hornberger F.R. Nucleotide sequence comparison of the membrane protein genes of three enterotropic strains of mouse hepatitis virus. Virus Res. 1994;31:49–56. doi: 10.1016/0168-1702(94)90070-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Hornberger F.R. Sequence analysis of the nucleoprotein genes of three enterotropic strains of murine coronavirus. Arch Virol. 1995;140:571–579. doi: 10.1007/BF01718432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Hornberger F.R., Barthold S.W. Passively acquired challenge immunity to enterotropic coronavirus in mice. Arch Virol. 1992;126:35–443. doi: 10.1007/BF01309682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Hornberger RR., Barthold S.W., Smith A.L. Duration and strain-specificity of immunity to enterotropic mouse hepatitis virus. Lab Anim Sci. 1992;42:347–351. [PubMed] [Google Scholar]
  121. Hornberger RR., Smith A.L., Barthold S.W. Detection of rodent coronavirus in tissues and cell cultures by using polymerase chain reaction. J Clin Microbiol. 1991;29:2789–2793. doi: 10.1128/jcm.29.12.2789-2793.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Hornberger F.R., Thomann P.E. Transmission of murine viruses and Mycoplasma in laboratory mouse colonies with respect to housing conditions. Lab Anim. 1994;28:113–120. doi: 10.1258/002367794780745263. [DOI] [PubMed] [Google Scholar]
  123. Hornberger RR., Zhang L., Barthold S.W. Prevalence of enterotropic and polytropic mouse hepatitis virus in enzootically infected mouse colonies. Lab Anim Sci. 1998;48:50–54. [PubMed] [Google Scholar]
  124. Houtman J.J., Fleming J.O. Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coro-navirus JHM. J Neurovirol. 1996;2:101–110. doi: 10.3109/13550289609146543. [DOI] [PubMed] [Google Scholar]
  125. Huang D.S., Emancipator S.N., Fletcher D.R., Lamm M.E., Mazanec M.B. Hepatic pathology resulting from mouse hepatitis virus S infection in severe combined immunodeficiency mice. Lab Anim Sci. 1996;46:442–4446. [PubMed] [Google Scholar]
  126. Ishida T., Fujiwara K. Maternally derived immune resistance to fatal diarrhea in infant mice to mouse hepatitis virus. Jpn J Exp Med. 1982;52:231–235. [PubMed] [Google Scholar]
  127. Ishida T., Fujiwara K. Pathology of diarrhea due to mouse hepatitis virus in the infant mouse. Jpn J Exp Med. 1979;49:33–441. [PubMed] [Google Scholar]
  128. Ishida T., Taguchi R, Lee Y.-S., Yamada A., Tamura T., Fujiwara K. Isolation of mouse hepatits virus from infant mice with fatal diarrhea. Lab Anim Sci. 1978;28:269–283. [PubMed] [Google Scholar]
  129. Ishida T., Tamura T., Ueda R, Fujiwara K. Hepatosplenic myelosis in the nude mouse naturally infected with mouse hepatitis virus. Jpn J Vet Sci. 1978;40:739–743. doi: 10.1292/jvms1939.40.739. [DOI] [PubMed] [Google Scholar]
  130. Jolicoeur P., Lamontagne L. Impairment of bone marrow pre-B and B cells in MHV3 chronically-infected mice. Adv Exp Med Biol. 1995;380:193–195. doi: 10.1007/978-1-4615-1899-0_33. [DOI] [PubMed] [Google Scholar]
  131. Kai C., Tamura T., Fujiwara K. Effect of immune heterozygous spleen cells transfer on resistance to mouse hepatitis virus infection in nude mice. Microbiol Immunol. 1981;25:1011–1018. doi: 10.1111/j.1348-0421.1981.tb00107.x. [DOI] [PubMed] [Google Scholar]
  132. Katami K., Taguchi R, Nakayama M., Goto N., Fujiwara K. Vertical transmission of mouse hepatitis virus infection in mice. Jpn J Exp Med. 1978;48:481–490. [PubMed] [Google Scholar]
  133. Keck J.G., Makino S., Soe L.H., Fleming J.O., Stohlman S.A., Lai M.M.C. RNA recombination of coronavirus. Adv Exp Med Biol. 1987;218:99–107. doi: 10.1007/978-1-4684-1280-2_11. [DOI] [PubMed] [Google Scholar]
  134. Keck J.G., Matsushima G.K., Makino S. In vivo RNA-RNA recombination of coronavirus in mouse brain. J Virol. 1988;62:1810–1813. doi: 10.1128/jvi.62.5.1810-1813.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Keck J.G., Soe L.H., Makino S., Stohlman S.A., Lai M.M. RNA recombination of murine coronaviruses: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J Virol. 1988;62:1989–1998. doi: 10.1128/jvi.62.6.1989-1998.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Kersting G., Pette E. Zur pathohistologic und pathogenese der exper-imentellin JHM-virusencephalomyelitis des affen. Deutsch Z Nervenheilk. 1956;174:283–304. [PubMed] [Google Scholar]
  137. Knobler R.L., Haspel M.V., Oldstone M.B. Mouse hepatitis virus type 4 (JHM strain)-induced fatal central nervous system disease. 1. Genetic control and the murine neuron as the susceptible site of disease. J Exp Med. 1981;153:832–843. doi: 10.1084/jem.153.4.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Koetters P.J., Hassanieh L., Stohlman S.A., Gallagher T., Lai M.M.C. Mouse hepatitis virus strain JHM infects a human hepatocellular car-cinoma cell line. Virology. 1999;264:398–409. doi: 10.1006/viro.1999.9984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Kolb A.J., Pewe L., Webster J., Perlman S., Whitelaw C.B., Siddel S.G. Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus-induced encephalitis. J Virol. 2001;75:2803–2809. doi: 10.1128/JVI.75.6.2803-2809.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Koo M., Bendahmane M., Lettieri G.A. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epi-tope. Proc Natl Acad Sci USA. 1999;96:7774–7779. doi: 10.1073/pnas.96.14.7774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Koolen M.J., Osterhaus A.D., VanSteenis G., Horzinek M.C., vanderZeijst B.A.M. Temperature-sensitive mutants of mouse hepatitis virus strain A59: isolation characterization and neuropathogenic properties. Virology. 1983;125:393–402. doi: 10.1016/0042-6822(83)90211-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Kraft L. An apparantly new lethal virus disease of infant mice. Science. 1962;137:282–283. doi: 10.1126/science.137.3526.282. [DOI] [PubMed] [Google Scholar]
  143. Kraft L. Epizootic diarrhea of infant mice and lethal intestinal virus infection of infant mice. Nat Cancer Inst Monogr. 1966;20:55–61. [PubMed] [Google Scholar]
  144. Krueger D.K., Kelly S.M., Lewicki D.N., Ruffolo R., Gallagher T.M. Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion. J Virol. 2000;75:2792–2802. doi: 10.1128/JVI.75.6.2792-2802.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Kunita S., Zhang L., Hornberger F.R., Compton S.R. Molecular characterization of the S proteins of two enterotropic murine coronaviruses. Virus Res. 1995;35:277–289. doi: 10.1016/0168-1702(94)00089-U. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Kyuwa S. Replication of mouse hepatitis virus in mouse embryonic stem cell lines in vitro. Exp Anim. 1997;46:311–313. doi: 10.1538/expanim.46.311. [DOI] [PubMed] [Google Scholar]
  147. Kyuwa S., Machii K., Shibata S. Role of CD4+ and CD8+ T cells in mouse hepatitis virus infection in mice. Exp Anim. 1996;45:81–83. doi: 10.1538/expanim.45.81. [DOI] [PubMed] [Google Scholar]
  148. Kyuwa S., Nishikawa T., Kaneko T. Experimental evaluation of cross-contamination between cryotubes containing mouse 2-cell embryos and murine pathogens in liquid nitrogen tanks. Exp Anim. 2003;52:67–70. doi: 10.1538/expanim.52.67. [DOI] [PubMed] [Google Scholar]
  149. Kyuwa S., Ohsawa K., Sato H., Urano T. Replication of enterotropic and polytropic murine coronaviruses in cultured cell lines of mouse origin. Exp Anim. 2000;49:251–257. doi: 10.1538/expanim.49.251. [DOI] [PubMed] [Google Scholar]
  150. Kyuwa S., Shibata S., Tagawa Y., Iwakura Y., Machii K., Urano T. Acute hepatic failure in IFN-gamma-deficient BALB/c mice after murine coronavirus infection. Virus Res. 2002;83:169–177. doi: 10.1016/S0168-1702(01)00432-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Kyuwa S., Tagawa Y., Machii K. MHV-induced fatal peritonitis in mice lacking IFN-gamma. Adv Exp Med Biol. 1998;440:445–450. doi: 10.1007/978-1-4615-5331-1_56. [DOI] [PubMed] [Google Scholar]
  152. Kyuwa S., Tagawa Y., Shibata S., Doi K., Machii K., Iwakura Y. Murine coronavirus-induced subacute fatal peritonitis in C57BL/6 mice defi-cient in gamma interferon. J Virol. 1998;72:9286–9290. doi: 10.1128/jvi.72.11.9286-9290.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Kyuwa S., Yamaguchi K., Toyoda Y., Fujiwara K. Induction of self-reactive T cells after murine coronavirus infection. J Virol. 1991;65:1789–1795. doi: 10.1128/jvi.65.4.1789-1795.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Lai M.M. Coronavirus: organization replication and expression of genome. Annu Rev Microbiol. 1990;44:303–333. doi: 10.1146/annurev.mi.44.100190.001511. [DOI] [PubMed] [Google Scholar]
  155. Lai M.M. Genetic recombination in RNA viruses. Curr Top Microbiol Immunol. 1992;176:21–32. doi: 10.1007/978-3-642-77011-1_2. [DOI] [PubMed] [Google Scholar]
  156. Lai M.M., Baric R.S., Makino S. Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol. 1985;56:449–456. doi: 10.1128/jvi.56.2.449-456.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Lai M.M., Fleming J.O., Stohlman S.A., Fujiwara K. Genetic heterogeneity of murine coronaviruses. Arch Virol. 1983;78:167–175. doi: 10.1007/BF01311312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Lai M.M.C, Holmes K.V. Coronaviridae: the viruses and their replication. In: Knipe D.M., Howley P.M., editors. Vol. 1. Lippincott Williams and Wilkins; Philadelphia: 2001. pp. 1163–1185. (Fields virology). [Google Scholar]
  159. Lamontagne L., Descoteaux J.P., Jolicoeur P. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenic-ity. J Immunol. 1989;142:4458–4465. [PubMed] [Google Scholar]
  160. Lamontagne L., Jolicoeur P. Low-virulence mouse hepatitis viruses exhibiting various tropisms in macrophages T and B cell subpopu-lations and thymic stromal cells. Lab Anim Sci. 1994;44:17–24. [PubMed] [Google Scholar]
  161. Lamontagne L.M., Dupuy J.P. Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines. Infect Immun. 1984;44:716–723. doi: 10.1128/iai.44.3.716-723.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Lampert P.W., Sims J.K., Kniazeff A.J. Mechanisms of demyeli-nation in JHM virus encephalomyelitis. Acta Neuropathol. 1973;24:76–85. doi: 10.1007/BF00691421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Lane T.E., Asensio V.C., Yu N., Paoletti A.D., Campbell I.L., Buchmeier M.J. Dynamic regulation of alpha and beta chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol. 1998;160:970–978. [PubMed] [Google Scholar]
  164. Lane T.E., Liu M.T., Chen B.P. A central role for CD4+ T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol. 2000;74:1415–1424. doi: 10.1128/jvi.74.3.1415-1424.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Lavi E., Fishman P.S., Highkin M.K., Weiss S.R. Limbic encephalitis after inhalation of a murine coronavirus. Lab Invest. 1988;58:31–36. [PubMed] [Google Scholar]
  166. Lavi E., Gilden D.H., Highkin M.K., Weiss S.R. The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoc-ulation. Lab Anim Sci. 1986;36:130–135. [PubMed] [Google Scholar]
  167. Lecomte J., Cainelli-Gebara V., Mercier G. Protection from mouse hepatitis virus type 3-induced acute disease by an anti-nucleocapsid monoclonal antibody. Arch Virol. 1987;97:123–130. doi: 10.1007/BF01310740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Lehoux M., Jacques A., Lusignan S., Lamontagne L. Murine viral hepatitis involves NK cell depletion associated with virus-induced apoptosis. Clin Exp Immunol. 2004;137:41–51. doi: 10.1111/j.1365-2249.2004.02501.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. LePrevost C., Levy-Leblond E., Virelizier J.L., Dupuy J.M. Immunopathology of mouse hepatitis virus type 3 infection. I. Role of humoral and cell-mediated immunity in resistance mechanism. J Immunol. 1975;114:221–225. [PubMed] [Google Scholar]
  170. Levy G.A., Leibowitz J.L., Edington T.S. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease sus-ceptibility in mice. J Exp Med. 1981;154:1150–1163. doi: 10.1084/jem.154.4.1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Levy-Leblond E., Dupuy J.M. Neonatal susceptibility to MHV 3 infection in mice. I. Transfer of resistance. J Immunol. 1977;118:1219–1222. [PubMed] [Google Scholar]
  172. Liang S.C., Lian W.C., Leu F.J. Epizootic of low-virulence hepatotropic murine hepatitis virus in a nude mice breeding colony in Taiwan. Lab Anim Sci. 1995;45:519–522. [PubMed] [Google Scholar]
  173. Lin M.T., Hinton D.R., Marten N.W., Bergmann C.C., Stohlman S.A. Antibody prevents virus reactivation within the central nervous system. J Immunol. 1999;162:7358–7368. [PubMed] [Google Scholar]
  174. Lin M.T., Stohlman S.A., Hinton D.R. Mouse hepatitis virus is cleared from the central nervous system of mice lacking perforin-mediated cytolysis. J Virol. 1997;71:383–391. doi: 10.1128/jvi.71.1.383-391.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Lindsey J.R., Boorman G.A., Collins J.M.J., Hsu C.-K., VanHoosier G.L., Jr., Wagner J.E. Institute of Laboratory Animal Resources National Research Council National Academy of Sciences; Washington DC: 1991. Infectious diseases of mice and rats. [Google Scholar]
  176. Lipman N.S., Corning B.F., Saifuddin M. Evaluation of isolator caging systems for protection of mice against challenge with mouse hepati-tis virus. Lab Anim. 1993;27:134–140. doi: 10.1258/002367793780810360. [DOI] [PubMed] [Google Scholar]
  177. Liu M.F., Ning Q., Pope M. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1 but not a Th2 response whereas pre-existing antibody partially protects against primary infection. Adv Exp Med Biol. 1998;440:415–423. doi: 10.1007/978-1-4615-5331-1_52. [DOI] [PubMed] [Google Scholar]
  178. Lucas A., Coulter M., Anderson R., Dales S., Flintoff W. In vivo and in vitro models of demyelinating diseases. II. Persistence and host-regulated thermosensitivity in cells of neural derivation infected with mouse hepatitis and measles viruses. Virology. 1978;88:325–337. doi: 10.1016/0042-6822(78)90289-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Luytjes W., Bredenbeek P.J., Noten A.F., Horzinek M.C., Spaan W.J. Sequence of mouse hepatitis virus A59 mRNA-2: indications for RNA recombination between coronaviruses and influenza C virus. Virology. 1988;166:415–422. doi: 10.1016/0042-6822(88)90512-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Luytjes W., Geerts D., Posthumus W., Meloen R., Spaan W. Amino acid sequence of a conserved neutralizing epitope of murine coro-naviruses. J Virol. 1989;63:1408–1412. doi: 10.1128/jvi.63.3.1408-1412.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. MacPhee P.J., Dindzans V.J., Fung L.S., Levy G.A. Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infecion with mouse hepatitis virus type 3. Hepatology. 1985;5:649–660. doi: 10.1002/hep.1840050422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Makino S., Keck J.G., Stohlman S.A., Lai M.M. High-frequency RNA recombination of murine coronaviruses. J Virol. 1986;57:729–737. doi: 10.1128/jvi.57.3.729-737.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Manaker R.A., Piczak C.W., Miller A.A., Stanton M.F. A hepatitis virus complicating studies with mouse leukemia. J Natl Cancer Inst. 1961;27:29–51. [PubMed] [Google Scholar]
  184. Marsden P.A., Ning Q., Fung L.S. The Fg12/fibroleukin pro-thrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest. 2003;112:58–66. doi: 10.1172/JCI18114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Marten N.W., Stohlman S.A., Atkinson R.D., Hinton D.R., Fleming J.O., Bergmann C.C. Contributions of CD8+ T cells and viral spread to demyelinating disease. J Immunol. 2000;164:4080–4088. doi: 10.4049/jimmunol.164.8.4080. [DOI] [PubMed] [Google Scholar]
  186. Marten N.W., Stohlman S.A., Bergmann C.C. MHV control of the CNS: mechanisms of immune-mediated control. Viral Immunol. 2001;14:1–18. doi: 10.1089/08828240151061329. [DOI] [PubMed] [Google Scholar]
  187. Mathews A.E., Lavi E., Weiss S.R., Paterson Y. Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59. J Neurovirol. 2002;8:257–264. doi: 10.1080/13550280290049697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Mathews A.E., Weiss S.R., Schlomchik M.J., Hannum L.G., Gombold J.L., Paterson Y. Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system but not the liver. J Immunol. 2001;167:5254–5263. doi: 10.4049/jimmunol.167.9.5254. [DOI] [PubMed] [Google Scholar]
  189. Matsuyama S., Henmi S., Ichihara N. Protective effects of murine recombinant interferon-beta administered by intravenous intramuscular or sub-cutaneous route on mouse hepatitis virus infection. Antiviral Res. 2000;47:131–137. doi: 10.1016/s0166-3542(00)00097-8. [DOI] [PubMed] [Google Scholar]
  190. Matthaei K.I., Berry J.R., France M.P., Yeo C., Garcia-Aragon J., Russell P.J. Use of polymerase chain reaction to diagnose a natural outbreak of mouse hepatitis virus in nude mice. Lab Anim Sci. 1998;48:137–144. [PubMed] [Google Scholar]
  191. Matthews A.E., Weiss S.R., Shlomchik M., Hannum L.G., Gombold J.L., Paterson Y. Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system but not the liver. J Immunol. 2001;167:5254–5263. doi: 10.4049/jimmunol.167.9.5254. [DOI] [PubMed] [Google Scholar]
  192. Miyazaki Y., Katsuta H., Aoyama Y., Kawai K., Takaoka T. Experimental studies on hepatitis virus of mice in tissue culture. Jpn J Exp Med. 1957;27:381–399. [PubMed] [Google Scholar]
  193. Morales S., Parra B., Ramakrishna C., Blau D.M., Stohlman S.A. B-cell-mediated lysis of cells infected with the neurotropic JHM strain of mouse hepatitis virus. Virology. 2001;286:160–167. doi: 10.1006/viro.2001.0991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Morris J.A. A new member of the hepato-encephalitis group of murine viruses. Proc Soc Exp Biol Med. 1959;100:875–877. [PubMed] [Google Scholar]
  195. Mosley J.W. Multiplication and cytopathogenicity of mouse hepatitis virus in mouse cell cultures. Proc Soc Exp Biol Med. 1961;108:524–529. doi: 10.3181/00379727-108-26986. [DOI] [PubMed] [Google Scholar]
  196. Murray R.S., Cai G.-Y., Hoel K., Zhang J.-Y., Soike K.F., Cabirac G.F. Coronavirus infects and causes demyelination in primate central nervous system. Virology. 1992;188:274–284. doi: 10.1016/0042-6822(92)90757-G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Nakanaga K., Yamanouchi K., Fujiwara K. Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J Virol. 1986;59:168–171. doi: 10.1128/jvi.59.1.168-171.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Nedellec P., Dveksler G.S., Daniels E. Bgp2 a new member of the carcinoembryonic antigen-related gene family encodes an alternative receptor for mouse hepatitis virus. J Virol. 1994;68:4525–44537. doi: 10.1128/jvi.68.7.4525-4537.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Nelson J.B. Acute hepatitis associated with mouse leukemia. I. Etiology and host range of the causal agent in mice. J Exp Med. 1952;96:303–312. doi: 10.1084/jem.96.4.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Nelson J.B. Acute hepatitis associated with mouse leukemia. II. Pathological features and transmission of the disease. J Exp Med. 1952;96:293–300. doi: 10.1084/jem.96.4.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Nicklas W., Kraft V., Meyer B. Contamination of transplantable tumors cell lines and monoclonal antibodies with rodent viruses. Lab Anim Sci. 1993;43:296–300. [PubMed] [Google Scholar]
  202. Ning Q., Lakatoo S., Liu M. Induction of prothrombinasefgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4 alpha. J Biol Chem. 2003;278:15541–15549. doi: 10.1074/jbc.M212806200. [DOI] [PubMed] [Google Scholar]
  203. Ning Q., Liu M., Kongkham P. The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 pro-thrombinase gene. J Biol Chem. 1999;274:9930–9936. doi: 10.1074/jbc.274.15.9930. [DOI] [PubMed] [Google Scholar]
  204. Ohtsuka N., Taguchi T. Mouse susceptibility to mouse hepatitis virus infection links with viral receptor genotype. J Virol. 1997;71:8860–8863. doi: 10.1128/jvi.71.11.8860-8863.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Ohtsuka N., Yamada Y.K., Saeki K., Taguchi F. Differential receptor-functionality of the two distinct receptor proteins for mouse hepati-tis virus. Adv Exp Med Biol. 1998;440:77–80. doi: 10.1007/978-1-4615-5331-1_10. [DOI] [PubMed] [Google Scholar]
  206. Ohtsuka N., Yamada Y.K., Taguchi F. Difference in virus-binding activity of two receptor proteins for mouse hepatitis virus. J Gen Virol. 1996;77:1683–1692. doi: 10.1099/0022-1317-77-8-1683. [DOI] [PubMed] [Google Scholar]
  207. Okumura A., Machii K., Azuma S., Toyoda Y., Kyuwa S. Maintenance of pluripotency in mouse embryonic stem cells persistently infected with murine coronavirus. J Virol. 1996;70:4146–4149. doi: 10.1128/jvi.70.6.4146-4149.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Oleszak E.L., Perlman S., Leibowitz J.L. MHV S peplomer protein expressed by a recombinant vaccinia virus vector exhibits IgG Fc-receptor activity. Virology. 1992;186:122–132. doi: 10.1016/0042-6822(92)90066-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Ontiveros E., Kim T.S., Gallagher T.M., Perlman S. Enhanced virulence mediated by the murine coronavirus mouse hepatitis virus strain JHM is associated with a glycine at residue 310 of the spike glycoprotein. Virology. 2003;77:10260–10269. doi: 10.1128/JVI.77.19.10260-10269.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  210. Orcutt R.P., Phelan R.S., Geistfeld J.G. Exclusion of mouse hep-atitis virus from a filtered plastic rodent shipping container during an in transit field challenge. Contemp Topics Lab Anim Sci. 2001;40:32–35. [PubMed] [Google Scholar]
  211. Oyanagi M, Kato A., Yamada Y.K., Sato N.L. Detection of MHV-RNAs in mouse intestines and in filter dust in mouse room ventilation duct by modified RT-nested PCR. Exp Anim. 2004;53:37–41. doi: 10.1538/expanim.53.37. [DOI] [PubMed] [Google Scholar]
  212. Paradisi F., Piccinino F. Propogation of mouse hepatitis virus (MHV-3) in monolayer cell cultures from liver of newborn mice. Experientia. 1968;24:373–374. doi: 10.1007/BF02140829. [DOI] [PubMed] [Google Scholar]
  213. Parker S.E., Gallagher T.M., Buchmeier M.J. Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glyco-protein gene of several strains of murine hepatitis virus. Virology. 1989;173:664–673. doi: 10.1016/0042-6822(89)90579-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Parra B., Hinton D.R., Marten N.W. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol. 1999;162:1641–1647. [PubMed] [Google Scholar]
  215. Percy D.H., Barthold S.W. Iowa State University Press; Ames IA: 1900. Pathology of laboratory rodents and rabbits. [Google Scholar]
  216. Perlman S., Jacobsen G., Moore S. Regional localization of virus in the central nervous system of mice persistently infected with murine coro-navirus JHM. Virology. 1988;166:328–338. doi: 10.1016/0042-6822(88)90503-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Perlman S., Jacobsen G., Olson A.L., Afifi A. Identification of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus. Virology. 1990;175:418–426. doi: 10.1016/0042-6822(90)90426-R. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Perlman S., Schelper R., Bolger E., Ries D. Late onset sympto-matic demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. Microb Pathog. 1987;2:185–194. doi: 10.1016/0882-4010(87)90020-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Peters R.L., Collins M.J., Jr., O'Beirne A.J., Hourihan S.L., Thomas S.F. Enzyme-linked immunosorbent assay for detection of antibodies to murine hepatitis virus. J Clin Microbiol. 1979;10:595–597. doi: 10.1128/jcm.10.4.595-597.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Peters R.L., Collins M.J., Jr. The enzyme-linked immunosorbent assay for mouse hepatitis and rat coronaviruses. Lab Anim. 1983;12:18–25. [PubMed] [Google Scholar]
  221. Pewe L., Haring J., Perlman S. T-cell-mediated demyelination is increased in the absence of gamma interferon in mice infected with mouse hepatitis virus. J Virol. 2002;76:7329–7333. doi: 10.1128/JVI.76.14.7329-7333.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Pewe L., Wu G.F., Barnett E.M., Castro R.F., Perlman S. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity. 1996;5:253–262. doi: 10.1016/s1074-7613(00)80320-9. [DOI] [PubMed] [Google Scholar]
  223. Pewe L., Xue S., Perlman S. Infection with cytotoxic T-lymphocyte escape mutants results in increased mortality and growth retardation in mice infected with neurotropic coronavirus. J Virol. 1998;72:5912–5918. doi: 10.1128/jvi.72.7.5912-5918.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Phillips J.J., Chua M.M., Lavi E., Weiss S.R. Pathogenesis of chimeric MHV-4/MHV-A59 recombinant virues: the murine coronavirus spike protein is a major determinant of neurovirulence. J Virol. 1999;73:7752–7760. doi: 10.1128/jvi.73.9.7752-7760.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Phillips J.J., Chua M.M., Rall G., Weiss S.R. Murine coronavirus spike glycoprotein mediates degree of viral spread inflammation and virus-induced immunopathology in the central nervous system. Virology. 2002;301:109–120. doi: 10.1006/viro.2002.1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. Piazza M. Charles C. Thomas; Springfield IL: 1969. Experimental viral hepatitis. [Google Scholar]
  227. Piccinino F., Galanti B., Guisti G. Lack of transplacental transmis-sibility of MHV-3 virus. Arch Ges Virusforsch. 1966;18:327–332. [Google Scholar]
  228. Pickel K., Muller M.A., TerMeulen V. Influence of maternal immu-nity on the outcome of murine coronavirus JHM infection in suckling mice. Med Microbiol Immunol. 1985;174:15–24. doi: 10.1007/BF02123666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Poon L.L.M., Guan Y., Nicholis J.M., Yuen K.Y., Peiris J.S.M. The aetiology origins and diagnosis of severe acute respiratory syndrome. Lancet. 2004;4:663–671. doi: 10.1016/S1473-3099(04)01172-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. Pope M., Chung S.W., Mosmann T., Leibowitz J.L., Gorczynski R.M., Levy G.A. Resistance of naive mice to murine hepatitis virus strain 3 requries development of a Th1 but not a Th2 response whereas pre-existing antibody partially protects against primary infection. J Immunol. 1996;156:3342–3349. [PubMed] [Google Scholar]
  231. Pope M., Marsden P.A., Cole E. Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide. J Virol. 1998;72:7084–7090. doi: 10.1128/jvi.72.9.7084-7090.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Pope M., Rotstein O., Cole E. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication. J Virol. 1995;69:5252–5260. doi: 10.1128/jvi.69.9.5252-5260.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Pullium J.K., Hornberger F.R., Benjamin K.A., Dillehay D.L., Huerkamp M.J. Confirmed persistent mouse hepatitis virus infec-tion and transmission by mice with a targeted null mutation of tumor necrosis factor to sentinel mice using short-term exposure. Comp Med. 2003;53:439–443. [PubMed] [Google Scholar]
  234. Raamsman M.J., Locker J.K., deHooge A. Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E. J Virol. 2000;74:2333–2342. doi: 10.1128/jvi.74.5.2333-2342.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  235. Ramakrishna C., Bergmann C.C., Atkinson R., Stohlman S.A. Control of central nervous system viral persistence by neutralizing antibody. J Virol. 2003;77:4670–4678. doi: 10.1128/JVI.77.8.4670-4678.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  236. Ramakrishna, et al, 1904.*Ramakrishna C., Bergmann C.C., Holmes K.V., Stohlman S.A. Expression of mouse hepatitis virus receptor by central nervous system microglia. J Virol. 1904;78:7828–7832. doi: 10.1128/JVI.78.14.7828-7832.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Ramakrishna C., Stohlman S.A., Atkinson R.D., Shlomchik M.J., Bergmann C.C. Mechanisms of central nervous system viral persis-tence: the critical role of antibody and B cells. J Immunol. 2002;168:1204–1211. doi: 10.4049/jimmunol.168.3.1204. [DOI] [PubMed] [Google Scholar]
  238. Rao P.V., Kumari S., Gallagher T.M. Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells. Virology. 1997;229:336–348. doi: 10.1006/viro.1997.8446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. Rehg J.E., Blackman M.A., Toth L.A. Persistent transmission of mouse hepatitis virus by transgenic mice. Comp Med. 2001;51:369–374. [PubMed] [Google Scholar]
  240. Rempel J.D., Murray S.J., Meisner J., Buchmeier M.J. Mouse hepatitis virus neurovirulence: evidence of a linkage between S glycoprotein expression and immunopathology. Virology. 2004;5:45–54. doi: 10.1016/j.virol.2003.08.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  241. Reynolds D.J., Gawes D.J. Virus isolation and serum antibody responses after infection of cats with transmissible gastroenteritis virus. Arch Virol. 1979;60:161–166. doi: 10.1007/BF01348032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  242. Rowe C.L., Baker S.C., Nathan M.J., Sgro J.Y., Palmenberg A.C., Fleming J.O. Quasispecies development by high-frequency RNA recombination during MHV persistence. Adv Exp Med Biol. 1998;440:759–765. doi: 10.1007/978-1-4615-5331-1_98. [DOI] [PubMed] [Google Scholar]
  243. Rowe W.P., Hartley J.W., Capps W.I. Mouse hepatitis virus infection as a highly contagious prevalent enteric infection of mice. Proc Soc Exp Biol Med. 1963;112:161–165. doi: 10.3181/00379727-112-27980. [DOI] [PubMed] [Google Scholar]
  244. Rowe W.P., Hartley J.W., Estes J.D., Huebner R.J. Studies on mouse polyomavirus infection. I. Procedures for quantitation and detection of virus. J. Exp Med. 1959;109:379–391. doi: 10.1084/jem.109.4.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Rulicke T., Chapuisat M., Hornberger F.R., Macas E., Wedekind C. MHC-genotype of progeny influenced by parental infection. Proc R Soc London B Biol Soc. 1998;265:711–716. doi: 10.1098/rspb.1998.0351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Ryder E.F., Snyder E.Y., Cepko C.L. Establishment and charac-terization of multipotent neural cell lines using retrovirus-mediated oncogene transfer. J Neurobiology. 1990;21:356–375. doi: 10.1002/neu.480210209. [DOI] [PubMed] [Google Scholar]
  247. Sawicki S.G., Liu J.-H., Holmes K.V. Persistent infection of cultured cells with mouse hepatitis virus (MHV) results from the epigenetic expression of the MHV receptor. J Virol. 1995;69:5535–5543. doi: 10.1128/jvi.69.9.5535-5543.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  248. Scavizzi F., Raspa M. Tissue distribution and duration of mouse hepatitis virus in naturally infected immunocompetent ICR (CD-1) and immunodeficient athymic nude-nu mouse strains used for ovarian transplan-tation and in vitro fertilization. Lab Anim. 2004;38:189–199. doi: 10.1258/002367704322968876. [DOI] [PubMed] [Google Scholar]
  249. Schickli J.H., Zelus B.D., Wentworth D.E., Sawicki S.G., Holmes K.V. The murine coronavirus mouse hepatitis virus strain A59 from per-sistently infected murine cells exhibits an extended host range. J Virol. 1997;71:9499–9507. doi: 10.1128/jvi.71.12.9499-9507.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  250. Schijns V.E., Wierda C.M., vanHoeij M., Horzinek M.C. Exacerbated viral hepatitis in IFN-gamma receptor-deficient mice is not suppressed by IL-12. J Immunol. 1996;157:815–821. [PubMed] [Google Scholar]
  251. Schwob J.E., Saha S., Youngentob S.L., Jubelt B. Intranasal inoculation with the olfactory bulb line variant of mouse hepatitis virus causes extensive destruction of the olfactory bulb and accelerated turnover of neurons in the olfactory epithelium of mice. Chem Senses. 2001;26:937–952. doi: 10.1093/chemse/26.8.937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Sebesteny A., Hill A.C. Hepatitis and brain lesions due to mouse hepatitis virus accompanied by wasting in nude mice. Lab Anim. 1974;8:317–326. doi: 10.1258/002367774780943733. [DOI] [PubMed] [Google Scholar]
  253. Shif I., Bang F.B. Plaque assay for mouse hepatitis virus (MHV-2) on primary macrophage cell cultures. Proc Soc Exp Biol Med. 1966;121:829–931. doi: 10.3181/00379727-121-30899. [DOI] [PubMed] [Google Scholar]
  254. Silagi S. Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance. J Cell Biol. 1969;43:263–274. doi: 10.1083/jcb.43.2.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  255. Smith A.L. An immunofluorescence test for detection of serum antibody to rodent coronaviruses. Lab Anim Sci. 1983;33:157–160. [PubMed] [Google Scholar]
  256. Smith A.L., Barthold S.W., Beck D.S. Intranasally administered alpha/beta interferon prevents extension of mouse hepatitis virus strain JHM into the brains of BALB/cByJ mice. Antiviral Res. 1987;8:239–246. doi: 10.1016/S0166-3542(87)80002-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  257. Smith A.L., Barthold S.W., deSouza M.S., Bottomly K. The role of gamma interferon in infection of susceptible mice with murine coro-navirus MHV-JHM. Arch Virol. 1991;121:89–100. doi: 10.1007/BF01316746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  258. Smith A.L., Cardellichio C.B., Winograd D.F., deSouza M.S., Barthold S.W., Holmes K.V. Monoclonal antibody to the receptor for murine coro-navirus MHV-A59 inhibits viral replication in vivo. J Infect Dis. 1991;163:879–882. doi: 10.1093/infdis/163.4.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  259. Smith A.L., Casals J., Main A.J. Antigenic characterization of Tettnang virus: complications caused by passage of the virus in mice from a colony enzootically infected with mouse hepatitis virus. Am J Trop Med Hyg. 1983;32:1172–1176. doi: 10.4269/ajtmh.1983.32.1172. [DOI] [PubMed] [Google Scholar]
  260. Smith A.L., de Souza M.S., Finzi D., Barthold S.W. Responses of mice to murine coronavirus immunization. Archiv Virol. 1992;125:39–52. doi: 10.1007/BF01309627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. Smith A.L., Winograd D.F. Two enzyme immunoassays for the detection of antibody to rodent coronaviruses. J Virol Methods. 1986;14:335–343. doi: 10.1016/0166-0934(86)90035-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  262. Smith A.L., Winograd D.F., deSouza M.S. In vitro splenic T cell responses of diverse mouse genotypes after oronasal exposure to mouse hepatitis virus strain JHM. Lab Anim Sci. 1991;41:106–111. [PubMed] [Google Scholar]
  263. Smith G.D., Solenberg P.J., Koenig M.C., Brune K.A., Fox N. Use of TaqMan reverse transcriptase-polymerase chain reaction analysis and sérologic testing to eliminate an enzootic infection of mouse hepatitis virus. Comp Med. 2002;52:456–460. [PubMed] [Google Scholar]
  264. Smith M.S., Click R.E., Plagemann P.G.W. Control of mouse hep-atitis virus replication in macrophages by a recessive gene on chromosome 7. J Immunol. 1984;134:428–432. [PubMed] [Google Scholar]
  265. Sorensen O., Dugre R., Percy D., Dales S. In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyeli-nating disease caused by mouse hepatitis virus in rats and mice. Infect Immun. 1982;37:2939–2952. doi: 10.1128/iai.37.3.1248-1260.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  266. Spaan W., Cavanagh D., Horzinek M.C. Coronaviruses: structure and genome expression. J Gen Virol. 1988;69:2939–2952. doi: 10.1099/0022-1317-69-12-2939. [DOI] [PubMed] [Google Scholar]
  267. Starr T.J., Pollard M. Propogation of mouse hepatitis virus (Gledhill) in tissue culture. Proc Soc Exp Biol Med. 1959;100:97–100. doi: 10.3181/00379727-100-24536. [DOI] [PubMed] [Google Scholar]
  268. Stauber R., Pfleiderera M., Siddell S. Proteolytic cleavage of the murine coronavirus surface glycoprotein is not required for fusion activity. J Gen Virol. 1993;74:183–191. doi: 10.1099/0022-1317-74-2-183. [DOI] [PubMed] [Google Scholar]
  269. Stohlman S.A., Bergmann C.C., Lin M.T., Cua D.J., Hinton D.R. CTL effector function within the central nervous system requires CD4+ T cells. J Immunol. 1998;160:2896–2904. [PubMed] [Google Scholar]
  270. Stohlman S.A., Bergmann C.C., vanderVeen R.C., Hinton D.R. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating it from the central nervous system. J. Virol. 1995;69:684. doi: 10.1128/jvi.69.2.684-694.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  271. Stohlman S.A., Braton P.R., Fleming J.O., Weiner L.P., Lai M.C. Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol. 1982;63:265–275. doi: 10.1099/0022-1317-63-2-265. [DOI] [PubMed] [Google Scholar]
  272. Stohlman S.A., Kyuwa S., Polo J.M., Brady D., Lai M.C., Bergmann C.C. Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J Virol. 1993;67:7050. doi: 10.1128/jvi.67.12.7050-7059.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  273. Stohlman S.A., Weiner L.P. Chronic central nervous system demyelination in mice after JHM virus infection. Neurology. 1981;31:38–44. doi: 10.1212/wnl.31.1.38. [DOI] [PubMed] [Google Scholar]
  274. Sturman L.S., Holmes K.V. The molecular biology of coronaviruses. Adv Virus Res. 1983;28:35–112. doi: 10.1016/S0065-3527(08)60721-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Sturman L.S., Holmes K.V. The novel glycoprotein of coronaviruses. Trends Biochem Sci. 1985;10:17–20. [Google Scholar]
  276. Sturman L.S., Holmes K.V., Behnke J. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J. Virol. 1980;33:449–462. doi: 10.1128/jvi.33.1.449-462.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  277. Sturman L.S., Takemoto K.K. Enhanced growth of a murine coronavirus in transformed mouse cells. Infect Immun. 1972;6:501–507. doi: 10.1128/iai.6.4.501-507.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  278. Sugiyama K., Amano Y. Hemagglutination and structural polypeptides of a new coronavirus associated with diarrhea in infant mice. Arch Virol. 1980;66:95–105. doi: 10.1007/BF01314978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  279. Sun N., Perlman S. Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes. J Virol. 1995;69:633–641. doi: 10.1128/jvi.69.2.633-641.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  280. Sutherland R.M., Chua M.M., Lavi E., Weiss S.R., Paterson Y. CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. J Neurovirol. 1997;3:225–228. doi: 10.3109/13550289709018297. [DOI] [PubMed] [Google Scholar]
  281. Suzuki H., Kiatipattanasakul W., Kajidawa S. Age-related changes in susceptibility of mice to low-virulent mouse hepatitis virus (MHV-2-CC) infection. Exp Anim. 1997;46:211–218. doi: 10.1538/expanim.46.211. [DOI] [PubMed] [Google Scholar]
  282. Suzuki H., Yorozu K., Watanabe T., Nakura M., Adachi J. Rederivation of mice by means of in vitro fertilization and embryo transfer. Exp Anim. 1996;45:33–38. doi: 10.1538/expanim.45.33. [DOI] [PubMed] [Google Scholar]
  283. Taguchi F., Goto Y., Aiuchi M., Hayashi T., Fujiwara K. Pathogenesis of mouse hepatitis virus infection. The role of nasal epithelial cells as a primary target of low virulence virus MHV-S. Microbiol Immunol. 1979;23:249–262. doi: 10.1111/j.1348-0421.1979.tb00461.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  284. Taguchi F., Shimazaki Y.K. Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity. J Gen Virol. 2000;81:2867–2871. doi: 10.1099/0022-1317-81-12-2867. [DOI] [PubMed] [Google Scholar]
  285. Taguchi F., Yamada A., Fujiwara K. Asymptomatic infection of mouse hepatitis virus in the rat. Arch Virol. 1979;59:275–279. doi: 10.1007/BF01317424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  286. Taguchi F., Yamada A., Fujiwara K. Factors involved in the age-dependent resistance of mice infected with low-virulence mouse hepatitis virus. Arch Virol. 1979;62:333–340. doi: 10.1007/BF01318107. [DOI] [PubMed] [Google Scholar]
  287. Takakura A., Ohnishi Y., Itoh T., Yoshimura M., Urano K., Ueyama Y. Decontamination of human xenotransplantable tumor with mouse hepatitis virus by implantation in nude rat: a case report. Exp Anim. 2000;49:39–41. doi: 10.1538/expanim.49.39. [DOI] [PubMed] [Google Scholar]
  288. Tamura T., Taguchi F., Ueda F., Fujiwara K. Persistent infection with mouse hepatitis virus of low virulence in nude mice. Microbiol Immunol. 1977;21:683–691. doi: 10.1111/j.1348-0421.1977.tb00337.x. [DOI] [PubMed] [Google Scholar]
  289. Tardieu M., Hery C., Dupuy J.M. Neonatal susceptibility to MHV3 infection in mice. II. Role of natural effector marrow cells in trans-fer of resistance. J. Immunol. 1980;124:418–423. [PubMed] [Google Scholar]
  290. Thackray L.B., Holmes K.V. Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coro-navirus MHV-A59. Virology. 2004;324:510–524. doi: 10.1016/j.virol.2004.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  291. Tooze J., Tooze S.A. Infection of AtT20 murine pituitary tumor cells by mouse hepatitis virus strain A59: virus budding is restricted to the Golgi region. Eur J Cell Biol. 1985;37:203–212. [PubMed] [Google Scholar]
  292. Tschen S., Bergmann C.C., Ramakrishna C., Morales S., Atkinson R., Stohlman S.A. Recruitment kinetics and composition of antibody secreting cells within the central nervous system following viral encephalomyelitis. J Immunol. 2002;168:2922–2929. doi: 10.4049/jimmunol.168.6.2922. [DOI] [PubMed] [Google Scholar]
  293. Uetsuka K., Nakayama H., Goto N. Hepatitogenicity of three plaque purified variants of hepatotropic mouse hepatitis virus MHV-2 in athymic nude mice. Exp Anim. 1996;45:183–187. doi: 10.1538/expanim.45.183. [DOI] [PubMed] [Google Scholar]
  294. Uetsuka K., Nakayama H., Goto N. Protective effect of recombinant interferon (IFN)-alpha/beta on MHV-2cc-induced chronic hepatitis in athymic nude mice. Exp Anim. 1996;45:293–297. doi: 10.1538/expanim.45.293. [DOI] [PubMed] [Google Scholar]
  295. Uetsuka K., Nakayama H., Goto N., Fujiwara K. Severe combined immunodeficiency (SCID) mouse hepatitis experimentally induced with low virulence mouse hepatitis virus. Adv Exp Med Biol. 1995;380:105–107. doi: 10.1007/978-1-4615-1899-0_16. [DOI] [PubMed] [Google Scholar]
  296. Vainio T. Studies on murine hepatitis virus (MHV3) in vitro. Proc Soc Exp Biol Med. 1961;107:326–331. doi: 10.3181/00379727-107-26616. [DOI] [PubMed] [Google Scholar]
  297. van der Hoek L., Pyrc K., Jebbink W.F. Identification of a new human coronavirus. Nat Med. 2004;10:368–373. doi: 10.1038/nm1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  298. van der Meer Y., Snijder E.J., Dobbe J.C. Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication. J Virol. 1999;73:7641–7657. doi: 10.1128/jvi.73.9.7641-7657.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  299. Virelizier J.L., Allison A.C. Correlation of persistent mouse hep-atitis virus (MHV-3) infection with its effect on mouse macrophage cultures. Archiv Virol. 1976;50:279. doi: 10.1007/BF01317953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  300. Wang F., Stohlman S., Fleming J. Demyelination induced by murine hepatitis virus JHM (MHV-4) is immunologically mediated. J Neuroimmunol. 1990;30:31–41. doi: 10.1016/0165-5728(90)90050-W. [DOI] [PMC free article] [PubMed] [Google Scholar]
  301. Wang F.I., Fleming J.O., Lai M.M. Sequence analysis of the spike glycoprotein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity. Virology. 1992;186:742–749. doi: 10.1016/0042-6822(92)90041-M. [DOI] [PMC free article] [PubMed] [Google Scholar]
  302. Ward J.M., Collins M.J., Jr., Parker J.C. Naturally occurring mouse hepatitis virus infection in the nude mouse. Lab Anim Sci. 1977;27:372–376. [PubMed] [Google Scholar]
  303. Ward J.M., Fox J.G., Anver M.R. Chronic active hepatitis and associated liver tumours in mice caused by persistent bacterial infection with a Helicobacter species. J Natl Cancer Inst. 1994;86:1222–1227. doi: 10.1093/jnci/86.16.1222. [DOI] [PubMed] [Google Scholar]
  304. Wege H., Watanabe R., terMeulen V. Coronavirus JHM infection of rats as a model for virus induced demyelinating encephalitis. Prog Clin Biol Res. 1984;146:13–22. [PubMed] [Google Scholar]
  305. Wege H., Winter J., Meyermann R. The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis. J Gen Virol. 1988;69:87–98. doi: 10.1099/0022-1317-69-1-87. [DOI] [PubMed] [Google Scholar]
  306. Weiner L.P. Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus) Arch Neurol. 1973;28:298–303. doi: 10.1001/archneur.1973.00490230034003. [DOI] [PubMed] [Google Scholar]
  307. Weir E.C., Bhatt P.N., Barthold S.W., Simack P.A. Elimination of mouse hepatitis virus from a breeding colony by temporary cessation of breeding. Lab Anim Sci. 1987;37:455–458. [PubMed] [Google Scholar]
  308. Welsh R.M., Haspel M.V., Parker D.C., Holmes K.V. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype. J Immunol. 1986;136:1454–1460. [PubMed] [Google Scholar]
  309. Wesseling J.G., Godeke G.J., Schijns V.E. Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection. J. Gen Virol. 1993;74:2061–2069. doi: 10.1099/0022-1317-74-10-2061. [DOI] [PubMed] [Google Scholar]
  310. Wilberz S., Partke HJ., Dagnaes-Hansen F., Herberg L. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia. 1991;34:2–5. doi: 10.1007/BF00404016. [DOI] [PubMed] [Google Scholar]
  311. Williams R.K., Jiang G.S., Holmes K.V. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci USA. 1991;88:5533–5536. doi: 10.1073/pnas.88.13.5533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  312. Woods R.D., Cheville N.F., Gallagher J.E. Lesions in the small intestine of newborn pigs inoculated with feline and canine coronavirus. Amer J Vet Res. 1981;42:1163–1169. [PubMed] [Google Scholar]
  313. Wu G.F., Dandekar A.A., Pewe L., Perlman S. CD4 and CD8 cells have redundant but not identical roles in virus-induced demyelination. J Immunol. 2000;165:2278–2286. doi: 10.4049/jimmunol.165.4.2278. [DOI] [PubMed] [Google Scholar]
  314. Wu G.F., Perlman S. Macrophage infiltration but not apoptosis is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J Virol. 1999;73:8771–8780. doi: 10.1128/jvi.73.10.8771-8780.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  315. Xu Y., Liu Y., Lou Z. Structural basis for coronavirus-mediated membrane fusion. J Biol Chem. 2004;279:30514–30522. doi: 10.1074/jbc.M403760200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  316. Xue S., Perlman S. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus. Virology. 1997;238:68–78. doi: 10.1006/viro.1997.8819. [DOI] [PubMed] [Google Scholar]
  317. Yamachuchi K., Goto N., Kyuwa S., Hayami M., Toyoda Y. Protection of mice from lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J Neuroimmunol. 1991;32:1–9. doi: 10.1016/0165-5728(91)90065-F. [DOI] [PMC free article] [PubMed] [Google Scholar]
  318. Yamada Y.K., Yabe M., Kyuwa S., Nakamura N., Takimoto K., Urano T. Differentiation of mouse hepatitis viruses in animal facilities in Japan by use of nucleotide analysis of the nucleocapsid gene. Comp Med. 2001;51:319–325. [PubMed] [Google Scholar]
  319. Yamaguchi K., Kyuwa S., Nakanaga K., Hayami M. Establishment of cytotoxic T-cell clones specific for cells infected with mouse hepatitis virus. J Virol. 1988;62:2505–2507. doi: 10.1128/jvi.62.7.2505-2507.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  320. Yokomori K., Asanaka M., Stohlman S.A., Lai M.M. A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry. Virology. 1993;196:45–56. doi: 10.1006/viro.1993.1453. [DOI] [PubMed] [Google Scholar]
  321. Yokomori K., Banner L.R., Lai M.M. Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coro-naviruses. Virology. 1991;183:647–657. doi: 10.1016/0042-6822(91)90994-M. [DOI] [PMC free article] [PubMed] [Google Scholar]
  322. Yokomori K., Lai M.M. Mouse hepatitis virus receptors: more than a single carcinoembryonic antigen. Arch Virol Suppl. 1994;9:461–471. doi: 10.1007/978-3-7091-9326-6_45. [DOI] [PubMed] [Google Scholar]
  323. Yokomori K., Lai M.M.C. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. 1992;66:6194–6199. doi: 10.1128/jvi.66.10.6194-6199.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  324. Yokomori K., Lai M.M.C. The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection. J Virol. 1992;66:6931–6938. doi: 10.1128/jvi.66.12.6931-6938.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  325. Yokomori K., LaMonica N., Makino S., Shieh C.K., Lai M.M. Biosynthesis structure and biological activities of envelope protein gp65 of murine coronavirus. Virology. 1989;173:683–691. doi: 10.1016/0042-6822(89)90581-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  326. Youngentob S.L., Schwob J.E., Saha S., Manglapus G., Jubelt B. Functional consequences following infection of the olfactory system by intranasal infusion of the olfactory bulb line variant (OBLV) of mouse hepatitis virus strain JHM. Chem Senses. 2001;26:953–963. doi: 10.1093/chemse/26.8.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  327. Yu X., Bi W., Weiss S.R., Leibowitz J.L. Mouse hepatitis virus gene 5b protein is a new virion envelope protein. Virology. 1994;202:1018–1023. doi: 10.1006/viro.1994.1430. [DOI] [PubMed] [Google Scholar]

Articles from The Mouse in Biomedical Research are provided here courtesy of Elsevier

RESOURCES